Dr Simon Thomas, CEO of Paragraf, on Adopter's Scaling Green-Tech podcast
April 1, 2026

Episode 22: Dr Simon Thomas (Paragraf) - Scaling Graphene From Cambridge Lab to World-First Foundry

Logo of Adopter - the marketing agency for deep tech and climate adaptation.

Dr Simon Thomas, Co-Founder and CEO of Paragraf, discusses scaling graphene from a Cambridge University invention to a commercial semiconductor foundry on Episode 22 of Scaling Green Tech, a podcast by Adopter.

Thomas traces Paragraf's eight-year journey from university spin-out to opening the world's first graphene foundry in Huntingdon, UK. The company's core breakthrough is the ability to deposit uniform, wafer-scale graphene directly onto substrates compatible with standard semiconductor manufacturing equipment - solving the "lab to fab" problem that has blocked graphene commercialisation since the material was first isolated at the University of Manchester in 2004. Paragraf has raised approximately $150 million in total across seed, Series A, Series B ($60 million led by New Science Ventures), and Series C ($55 million led by Mubadala), and has expanded internationally with operations in San Diego, Shanghai, and Abu Dhabi. Thomas argues that graphene devices could reduce the computing industry's share of global energy consumption from approximately 20% to under 2%, while also enabling new product categories in medical diagnostics and next-generation battery technology.

This episode is relevant for deep tech founders navigating multi-stage fundraising, semiconductor and advanced materials investors, climate technology founders building hardware companies, and anyone working on energy-efficient computing, point-of-care diagnostics, or graphene electronics.

Guest Profile

Dr Simon Thomas is Co-Founder and CEO of Paragraf. Before co-founding the company, Thomas spent 12 years in the semiconductor equipment industry in a materials science role, working primarily in fabrication facilities and laboratories. He subsequently joined Sir Colin Humphreys at Cambridge University, where the graphene deposition breakthrough that became Paragraf's core IP originated.

Paragraf is an integrated device manufacturer that produces wafer-scale graphene and builds it into electronic devices. The company describes itself as having opened the world's first graphene foundry in Huntingdon, UK, with its first wafers processed in December 2025. Paragraf has operations in San Diego (via acquisition of a US graphene company), Shanghai, and Abu Dhabi. The company has raised approximately $150 million across four funding rounds, with investors including IQ Capital, Parkwalk Advisors, Amadeus, Cambridge Enterprise, Molten Ventures, New Science Ventures, and Mubadala.

Company website: https://www.paragraf.com/.

Find Dr Simon Thomas on LinkedIn.

Key Takeaways

  • Paragraf processed its first six-inch wafers of graphene electronic devices through a full semiconductor manufacturing line in December 2025, with devices yielding on the first run - a result Thomas describes as "almost near impossible" for a new material.
  • Graphene is about 150 times more conductive than silicon and uses a thousand times less power in device form, according to Thomas. He estimates that if graphene replaced silicon across computing, the industry's share of global energy consumption would drop from approximately 20% to under 2%.
  • Thomas cites 2020 figures indicating global data centres consumed more energy than the entire United Kingdom, and Bitcoin mining alone consumed more energy than the whole of Argentina - illustrating the scale of the energy problem in computing.
  • Paragraf has raised approximately $150 million in total across four rounds: a seed round (amount not disclosed), a Series A of about 16 million (currency not specified, raised from UK investors), a Series B of $60 million led by New Science Ventures, and a Series C of $55 million led by Mubadala. Thomas indicates he is approaching a Series D, and that since the December foundry milestone, investors are now approaching Paragraf rather than the other way around.
  • Over $2 billion was invested in graphene commercialisation by Samsung alone, contributing to widespread scepticism that graphene could be manufactured at commercial scale. Thomas identifies Paragraf's ability to use standard semiconductor equipment as the key differentiator from previous failed attempts.
  • Paragraf has developed a graphene-based biosensor chip that detects potassium in blood from a single drop in 20 seconds, replacing a process that currently requires blood draws, laboratory transport, and lab analysis. The same sensor platform can also detect PFAS (forever chemicals).
  • Thomas describes the narrative shift required at each fundraising stage. The seed round focused on proving tech transfer from university was possible. Series A was about getting MVPs into customer hands. Series B funded the foundry vision. Series C funded global expansion. At each stage, the messaging had to match what investors needed to see - not just what the company had built.
  • Paragraf targets mid-sized companies looking to overtake incumbents, rather than approaching the largest corporations directly. Thomas argues that large companies require long qualification and purchasing chains, while mid-level companies that see graphene as a competitive advantage over larger rivals have both the motivation and agility to adopt faster.
  • Thomas describes a three-level approach to entering target companies: the business development contact who discovers Paragraf at an event, the technical champion who understands the technology and advocates internally, and the decision-maker with buying power. Getting traction at all three levels - without approaching too early or too late - is what converts interest into commercial relationships.
  • Marketing and sales culture differs significantly by geography. Thomas notes that Asian markets (Japan, China, Taiwan) require highly technical, specification-led communication, the US requires high-energy, relationship-driven outreach and a willingness to pick up the phone, and UK investor pitches are more formal and data-driven. Founders scaling internationally need to adapt their approach by market rather than applying a single playbook.

FAQs

  1. What is graphene and why has it been difficult to commercialise? 

Graphene is a single layer of carbon atoms arranged in a crystalline lattice. It was first isolated at the University of Manchester in 2004 and demonstrated properties including extremely high electrical conductivity and low power consumption. Commercialisation has been blocked primarily by manufacturing challenges: producing large, uniform sheets of single-atom-thick material at the quality required for electronic devices has proven far more difficult than producing small laboratory samples. Paragraf's approach deposits graphene directly onto substrates compatible with standard semiconductor equipment, bypassing the manufacturing bottleneck that has stalled previous attempts.

  1. How much energy do data centres use globally? 

Paragraf CEO Dr Simon Thomas cites 2020 figures indicating global data centres consumed more energy than the entire United Kingdom, and Bitcoin mining alone consumed more than Argentina. Computing currently accounts for approximately 20% of global energy consumption. Thomas argues that graphene-based devices, which use approximately a thousand times less power than silicon equivalents, could reduce that figure to under 2% if widely adopted.

  1. What is a graphene foundry? 

A graphene foundry is a manufacturing facility that produces graphene-based electronic devices at commercial scale using semiconductor fabrication processes. Paragraf opened what it describes as the world's first graphene foundry in Huntingdon, UK, processing its first wafers in December. The foundry model allows external companies to commission custom graphene devices - similar to how silicon foundries manufacture chips designed by other companies - rather than Paragraf selling only its own products.

  1. What is the "lab to fab" challenge in advanced materials? 

The "lab to fab" challenge refers to the gap between demonstrating a material's properties in a research laboratory and manufacturing devices from that material at commercial scale. According to Paragraf CEO Dr Simon Thomas, this challenge has historically affected many advanced materials, including silicon in the 1950s and 1960s and compound semiconductors such as indium gallium arsenide in the 1970s. For graphene, the specific difficulty lies in producing large-area, crystalline sheets of single-atom-thick carbon at consistent quality - a problem Paragraf addresses by depositing graphene directly onto standard semiconductor substrates.

  1. What are graphene biosensors and how do they work? 

Graphene biosensors are electronic chips that use graphene's interaction with biological agents to detect specific substances. Paragraf has developed a biosensor that detects potassium levels in blood from a single drop in approximately 20 seconds - replacing a conventional process involving blood draws, laboratory transport, and lab analysis. The same platform can detect PFAS (forever chemicals). According to Thomas, the concept of solid-state biological detection on a chip has been theorised since the 1980s, but previous materials including silicon and compound semiconductors lacked the properties required for reliable function.

Topics Covered

  • Explaining graphene to non-technical audiences
  • The "lab to fab" challenge and why graphene commercialisation has stalled
  • Founding Paragraf and the transition from scientist to CEO
  • The mindset shift from technical founder to business leader
  • Fundraising stages from seed to Series C
  • Overcoming graphene's reputation as overhyped technology
  • The graphene foundry model and its launch
  • Energy efficiency of graphene versus silicon in computing
  • Graphene biosensors for medical diagnostics and PFAS detection
  • Prioritising markets when the application range is wide
  • Commercial strategy and identifying early adopter customers
  • Marketing a deep tech product when the market does not yet exist
  • Geographic differences in sales and investor culture across the UK, US, and Asia
  • Climate applications including batteries, solar cells, and EV technology

Related Content

Episode 21: Theresa Hoffmann - Rethinking Thermal Insulation with Bio-Based Materials

Episode 19: Paul Domjan (ENODA): Resolving the Energy Trilemma

Strategy & messaging for deep tech and climate adaptation companies    

About Scaling Green-Tech

Scaling Green-Tech by Adopter is a podcast for people shaping the future of climate technology - founders, investors, and ecosystem leaders at the forefront of adaptation and resilience solutions. As part of Adopter’s mission to accelerate the adoption of high-impact climate innovation, the podcast aims to amplify real voices and practical insights that can help others navigate the startup journey. These conversations go beyond the hype to bring real, unfiltered stories - the wins, the roadblocks and everything you need to know in between.  

Read the full transcript here
illustration of Earth